Fungal infections after lung transplantation (Q37218116)

19 August 2017

title

Fungal infections after lung transplantation (English)

1 reference

19 August 2017

1 reference

Amparo Solé

1

1 reference

19 August 2017

Miguel Salavert

series ordinal

2

1 reference

19 August 2017

publication date

1 April 2008

1 reference

19 August 2017

published in

Transplantation Reviews

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

89-104

1 reference

Pulmonary complications of solid organ and hematopoietic stem cell transplantation

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Current approaches to diagnosis and treatment of invasive aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus infections in lung transplant recipients: risk factors and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Fungal infections in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infectious complications of lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus infections in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus airway colonization and invasive disease after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Demolition of a hospital building by controlled explosion: the impact on filamentous fungal load in internal and external air

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

The clinical spectrum of pulmonary aspergillosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Fungal infections in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Late-onset invasive aspergillosis in organ transplant recipients in the current era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Voriconazole Prophylaxis in Lung Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infectious complications following isolated lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infectious complications of lung transplantation. Impact of cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Pre-emptive therapy with azoles in lung transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infections in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Disruption of the aortic anastomosis after heart-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Epidemiology and management of infections after lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Epidemiology of bloodstream infections in the first year after pediatric lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infectious pulmonary complications in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Risk factors for systemic fungal infections in liver transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Prophylaxis of invasive mycoses in solid organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Invasive mold infections in allogeneic bone marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Emerging and less common fungal pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Emerging fungal diseases: the importance of the host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Mucormycosis: an emerging disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Zygomycosis: the re-emerging fungal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Zygomycosis in the 1990s in a tertiary-care cancer center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Zygomycetes in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant pat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Mucormycosis of the bronchial anastomosis: a case of successful medical treatment and historic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

The use of a mesenteric artery of Roux-en-Y limb for hepatic arterial reconstruction after living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Scedosporium apiospermum fungemia in a lung transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Pulmonary scedosporium infection following lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Fusarium infection after solid-organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Primary pulmonary involvement of Fusarium solani in a lung transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Fusarium infections in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Cryptococcosis in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Clinical and radiologic factors associated with pulmonary nodule etiology in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aspergillus Galactomannan Antigen in the Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis in Lung Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

[Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Antifungal prophylaxis in transplant recipients: where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Variation in antifungal prophylaxis strategies in lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Safety of aerosolized amphotericin B lipid complex in lung transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aerosolised antibiotics: a critical appraisal of their use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Pharmacology of Systemic Antifungal Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Recent advances in antifungal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Toward more effective antifungal therapy: the prospects of combination therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Combination antifungal therapy: what can and should we expect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Antifungal combination therapy: clinical potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Immune reconstitution syndrome associated with opportunistic mycoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Allograft Loss in Renal Transplant Recipients with Cryptococcus Neoformans Associated Immune Reconstitution Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Immunorestitution disease involving the innate and adaptive response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.007

10.1016/J.TRRE.2007.12.007

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference